SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
International Baler Corporation (IBAL) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 32/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — IBAL
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.88
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.03
Book Value / Share$0.00
Revenue / Share$1.93
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2012 |
$232.92 |
$17.82B |
$1.21B |
6.8% |
| 2013 |
$0.13 |
$16.08M |
$683.19K |
4.2% |
| 2014 |
$0.14 |
$19.79M |
$714.42K |
3.6% |
| 2015 |
$0.16 |
$18.1M |
$812.37K |
4.5% |
| 2016 |
$0.02 |
$11.65M |
$90.41K |
0.8% |
| 2017 |
$0.01 |
$10.49M |
$73.36K |
0.7% |
| 2018 |
$0.06 |
$11.11M |
$310.23K |
2.8% |
| 2019 |
$-0.06 |
$9.53M |
$-323.61K |
-3.4% |
| 2020 |
$-0.08 |
$8.99M |
$-408.42K |
-4.5% |
| 2021 |
$-0.03 |
$10M |
$-130.81K |
-1.3% |
